General Psychiatry · 2020 · 13 citations · 6 references
MedicineHealth SciencesPsychiatryCommunity PsychiatryConsultation-liaison PsychiatryMental Health CareAnxiety DisordersConsultation-liaison MedicineInpatient Psychiatric CareMental HealthMental IllnessPsychiatric DiagnosisAffective Symptoms In DepressionClinical Team CollaborationConsultation-liaison ModelsIncidence Of Mental DisordersMedical Records ReviewMental Health ExperienceMental Health ImpactsPrevalence Of Mental Disorders
BACKGROUND: Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. AIMS: We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. METHODS: We analysed data from the psychiatric medical records of 329 patients with COVID-19 in the Shanghai Public Health Clinical Center from 20 January to 8 March 2020. We collected information including sociodemographic characteristics, whether patients received psychiatric consultation, mental health symptoms, psychiatric diagnoses, psychiatric treatments and severity level of COVID-19. RESULTS: Psychiatric consultations were received by 84 (25.5%) patients with COVID-19. The most common symptoms of mental health problems were sleep disorders (75%), anxiety (58.3%) and depressive symptoms (11.9%). The psychiatric consultation rate was highest in critically ill patients (69.2%), with affective symptoms or disturbed behaviour as their main mental health problems. Psychiatric diagnoses for patients who received consultation included acute stress reaction (39.3%), sleep disorders (33.3%), anxiety (15.5%), depression (7.1%) and delirium (4.8%). In terms of psychiatric treatments, 86.9% of patients who received psychiatric consultation were treated with psychotropic medications, including non-benzodiazepine sedative-hypnotic agents (54.8%), antidepressants (26.2%), benzodiazepines (22.6%) and antipsychotics (10.7%). Among the 76 patients who were discharged from the hospital, 79% had recovered from mental health problems and were not prescribed any psychotropic medications. The symptoms of the remaining 21% of patients had improved and they were prescribed medications to continue the treatment. CONCLUSIONS: This is the first study to report psychiatric consultations for patients with COVID-19. Our study indicated that a considerable proportion of patients with COVID-19, especially critically ill cases, experienced mental health problems. Given the remarkable effect of psychiatric treatments, we recommend that psychiatrists be timely and actively involved in the treatment of COVID-19.
6
Patients with mental health disorders in the COVID-19 epidemic
Hao Yao, Jianhua Chen, Yifeng Xu · The Lancet Psychiatry · 2020 · 1.5K citations · Full text
Care for Critically Ill Patients With COVID-19
Srinivas Murthy, Charles D. Gomersall, Robert Fowler · JAMA · 2020 · 822 citations
Medicine, Infectious Disease Control, Infectious Diseases +16
Qian Guo, Yuchen Zheng, Jia Shi et al. · Brain Behavior and Immunity · 2020 · 425 citations · Full text
Crisis Intervention Handbook: Assessment, Treatment, and Research
Mary Hartshorn · JAMA · 2001 · 111 citations